|
| |||||||||||||||||||||||||||||||||||
|
50 Percent, 26 to 49 Percent, or 0 to 25 Percent Reductions from Base Line in the Frequency of All Types of Major Seizures, Drop Attacks, and TonicClonic Seizures during the 16-Week Treatment Period." The errors in Table 1 and the legend to Figure 1 do not alter the methods, results, or discussion. We appreciate the opportunity to correct these errors.
Edwin Trevathan, M.D., M.P.H.
University of Kentucky College of Medicine
Lexington, KY 40538-0284
E. Lynette Mullens, M.D.
Glaxo Wellcome Research and Development
Greenford, Middlesex UB6 OHE, United Kingdom
Penelope Manasco, M.D.
Glaxo Wellcome Research and Development
Research Triangle Park, NC 27709
References
| |||||||||||||||||||||||||||||||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |